These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23345381)

  • 1. Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study.
    Ziech ML; Lavini C; Bipat S; Ponsioen CY; Spijkerboer AM; Stokkers PC; Nederveen AJ; Stoker J
    AJR Am J Roentgenol; 2013 Feb; 200(2):W170-7. PubMed ID: 23345381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease.
    Horsthuis K; Ziech ML; Bipat S; Spijkerboer AM; de Bruine-Dobben AC; Hommes DW; Stoker J
    Clin Imaging; 2011; 35(5):360-5. PubMed ID: 21872125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based score helps in assessing the severity and in follow-up of pediatric patients with perianal Crohn disease.
    Kulkarni S; Gomara R; Reeves-Garcia J; Hernandez E; Restrepo R
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):252-7. PubMed ID: 24121148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease.
    Ziech ML; Lavini C; Caan MW; Nio CY; Stokkers PC; Bipat S; Ponsioen CY; Nederveen AJ; Stoker J
    Eur J Radiol; 2012 Nov; 81(11):3019-27. PubMed ID: 22749801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn's disease: a feasibility study.
    Horsthuis K; Nederveen AJ; de Feiter MW; Lavini C; Stokkers PC; Stoker J
    J Magn Reson Imaging; 2009 Feb; 29(2):488-93. PubMed ID: 19161209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn's disease.
    Villa C; Pompili G; Franceschelli G; Munari A; Radaelli G; Maconi G; Cornalba GP
    Eur J Radiol; 2012 Apr; 81(4):616-22. PubMed ID: 21316171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease.
    Florie J; Wasser MN; Arts-Cieslik K; Akkerman EM; Siersema PD; Stoker J
    AJR Am J Roentgenol; 2006 May; 186(5):1384-92. PubMed ID: 16632735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults.
    Shenoy-Bhangle A; Nimkin K; Goldner D; Bradley WF; Israel EJ; Gee MS
    Pediatr Radiol; 2014 Jan; 44(1):23-9. PubMed ID: 24005981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
    Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.
    Tielbeek JA; Makanyanga JC; Bipat S; Pendsé DA; Nio CY; Vos FM; Taylor SA; Stoker J
    AJR Am J Roentgenol; 2013 Dec; 201(6):1220-8. PubMed ID: 24261360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients.
    Eliat PA; Dedieu V; Bertino C; Bouté V; Lacroix J; Constans JM; de Korvin B; Vincent C; Bailly C; Joffre F; de Certaines J; Vincensini D
    Magn Reson Imaging; 2004 May; 22(4):475-81. PubMed ID: 15120166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MR imaging of perianal fistulas.
    Spencer JA; Ward J; Beckingham IJ; Adams C; Ambrose NS
    AJR Am J Roentgenol; 1996 Sep; 167(3):735-41. PubMed ID: 8751692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.